The role of imaging in hepatocellular carcinoma: The present and future

Journal of Clinical Gastroenterology

Volumn 47, Issue SUPPL.1, 2013, Pages

  Davarpanah, Amir H ^a   Weinreb, Jeffrey C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

computed tomography; diffusion weighted imaging; dual energy CT; hepatobiliary contrast agents; hepatocellular carcinoma; iron and fat quantification; magnetic resonance imaging; MR elastography; perfusion CT and MRI; ultrasonography

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOXETIC ACID; SUPERPARAMAGNETIC IRON OXIDE;

ACUTE KIDNEY FAILURE; BLOOD VOLUME; CANCER STAGING; COLON CARCINOMA; CONFERENCE PAPER; DIFFUSION WEIGHTED IMAGING; DISEASE SURVEILLANCE; ECHOGRAPHY; ELASTOGRAPHY; HEMOCHROMATOSIS; HEMODIALYSIS; HUMAN; IMAGE GUIDED BIOPSY; INTRAVASCULAR SPACE; IONIZING RADIATION; KIDNEY FUNCTION; KUPFFER CELL; LIVER CELL CARCINOMA; LIVER FIBROSIS; LIVER PARENCHYMA; LIVER PERFUSION; MULTIDETECTOR COMPUTED TOMOGRAPHY; NEPHROGENIC SYSTEMIC FIBROSIS; NONALCOHOLIC FATTY LIVER; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OVARY CARCINOMA; PERFUSION WEIGHTED IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RADIATION DOSE REDUCTION; RADIATION EXPOSURE; RISK FACTOR; TUMOR BLOOD FLOW; X RAY TUBE;

CARCINOMA, HEPATOCELLULAR; DIAGNOSTIC IMAGING; FORECASTING; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84879958024     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31827f0d3d     Document Type: Conference Paper

References (37)

1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:153-156. (Pubitemid 32911406)
2. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002. CA Cancer J Clin. 2005;55:74-108.
3. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol. 2003;38(suppl 1): S136-S149.
4. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208-1236. (Pubitemid 43112690)
5. El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011; 365:1118-1127.
6. Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020-1022.
7. Sherman M. Modern approach to hepatocellular carcinoma. Curr Gastroenterol Rep. 2011;13:49-55.
8. Bolog N, Andreisek G, Oancea I, et al. And MR imaging of hepatocellular carcinoma. J Gastrointest Liver Dis. 2011;20: 181-189.
9. Pandharipande PV, Krinsky GA, Rusinek H, et al. Perfusion imaging of the liver: current challenges and future goals. Radiology. 2005;234:661-673. (Pubitemid 40250807)
10. Miles KA, Hayball MP, Dixon AK. Functional images of hepatic perfusion obtained with dynamic CT. Radiology. 1993;188:405-411. (Pubitemid 23216260)
11. Goh V, Ng QS, Miles K. Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? Invest Radiol. 2012;47:2-4.
12. Flohr TG, McCollough CH, Bruder H, et al. First performance evaluation of a dual-source CT (DSCT) system. Eur Radiol. 2006;16:256-268. (Pubitemid 43149624)
13. Altenbernd J, Heusner TA, Ringelstein A, et al. Dual-energy-CT of hypervascular liver lesions in patients with HCC: investigation of image quality and sensitivity. Eur Radiol. 2011;21:738-743.
14. Goldberg HI, Cann CE, Moss AA, et al. Noninvasive quantitation of liver iron in dogs with hemochromatosis using dual-energy CT scanning. Invest Radiol. 1982;17:375-380. (Pubitemid 12001763)
15. Raptopoulos V, Karellas A, Bernstein J, et al. Value of dualenergy CT in differentiating focal fatty infiltration of the liver from low-density masses. AJR Am J Roentgenol. 1991;157: 721-725.
16. Joe E, Kim SH, Lee KB, et al. Feasibility and accuracy of dualsource dual-energy CT for noninvasive determination of hepatic iron accumulation. Radiology. 2012;262:126-135.
17. Fierbinteanu-Braticevici C, Dina I, Petrisor A, et al. Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis. World J Gastroenterol. 2010;16:4784-4791.
18. Coursey CA, Nelson RC, Boll DT, et al. Dual-energy multidetector CT: how does it work, what can it tell us, and when can we use it in abdominopelvic imaging? Radiographics. 2010;30:1037-1055.
19. Schauer DA, Linton OW. NCRP Report No. 160, Ionizing Radiation Exposure of the Population of the United States, medical exposure-are we doing less with more, and is there a role for health physicists? Health Phys. 2009;97:1-5.
20. Brink JA, Amis ES Jr. Image Wisely: a campaign to increase awareness about adult radiation protection. Radiology. 2010;257:601-602.
21. Schindera ST, Nelson RC, Mukundan S Jr., et al. Hypervascular liver tumors: low tube voltage, high tube current multi-detector row CT for enhanced detection-phantom study. Radiology. 2008;246:125-132. (Pubitemid 350305035)
22. Prakash P, Kalra MK, Kambadakone AK, et al. Reducing abdominal CT radiation dose with adaptive statistical iterative reconstruction technique. Invest Radiol. 2010;45:202-210.
23. Lee JM, Choi BI. Hepatocellular nodules in liver cirrhosis: MR evaluation. Abdom Imaging. 2011;36:282-289.
24. Kamel IR, Bluemke DA, Ramsey D, et al. Role of diffusionweighted imaging in estimating tumor necrosis after chemoembolization of hepatocellular carcinoma. AJR Am J Roentgenol. 2003;181:708-710. (Pubitemid 37021839)
25. Ward J, Guthrie JA, Scott DJ, et al. Hepatocellular carcinoma in the cirrhotic liver: double-contrast MR imaging for diagnosis. Radiology. 2000;216:154-162. (Pubitemid 30434736)
26. Golfieri R, Grazioli L, Orlando E, et al. Which is the best MRI marker of malignancy for atypical cirrhotic nodules: hypointensity in hepatobiliary phase alone or combined with other features? Classification after Gd-EOB-DTPA administration. J Magn Reson Imaging. 2012;36:648-657.
27. Park MJ, Kim YK, Lee MW, et al. Small hepatocellular carcinomas: improved sensitivity by combining gadoxetic acidenhanced and diffusion-weighted MR imaging patterns. Radiology. 2012;264:761-770.
28. Do RK, Rusinek H, Taouli B. Dynamic contrast-enhanced MR imaging of the liver: current status and future directions. Magn Reson Imaging Clin N Am. 2009;17:339-349.
29. Baxter S, Wang ZJ, Joe BN, et al. Timing bolus dynamic contrast-enhanced (DCE) MRI assessment of hepatic perfusion: Initial experience. J Magn Reson Imaging. 2009;29: 1317-1322.
30. Rouviere O, Yin M, Dresner MA, et al. MR elastography of the liver: preliminary results. Radiology. 2006;240:440-448. (Pubitemid 44098640)
31. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol. 2007;5:1207-1213, e1202.
32. Taouli B, Ehman RL, Reeder SB. Advanced MRI methods for assessment of chronic liver disease. AJR Am J Roentgenol. 2009;193:14-27.
33. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2*mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106:1460-1465. (Pubitemid 41129616)
34. Kuhn JP, Hernando D, Munoz Del Rio A, et al. Effect of multipeak spectral modeling of fat for liver iron and fat quantification: correlation of biopsy with MR imaging results. Radiology. 2012;265:133-142.
35. Reeder SB, Cruite I, Hamilton G, et al. Quantitative assessment of liver fat with magnetic resonance imaging and spectroscopy. J Magn Reson Imaging. 2011;34:729-749.
36. Kuhn JP, Evert M, Friedrich N, et al. Noninvasive quantification of hepatic fat content using three-echo dixon magnetic resonance imaging with correction for T2, relaxation effects. Invest Radiol. 2011;46:783-897.
37. Kalisz KR, Davarpanah AH, Usman AA, et al. Detection of renal dysfunction by point-of-care creatinine testing in patients undergoing peripheral MR angiography. AJR Am J Roentgenol. 2011;197:430-435.